These types of carryover should not lead to the carryover of degradants or microbial contamination which could adversely alter the proven API impurity profile. The controls Employed in the manufacture of APIs to be used in medical trials need to be according to the phase of enhancement on the drug https://www.rilife.co/blog/active-pharma-ingredients-api-importers-suppliers-exporters-in-india/